Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 16 studies | 56% ± 21% | |
astrocyte | 12 studies | 32% ± 15% | |
smooth muscle cell | 12 studies | 33% ± 14% | |
basal cell | 9 studies | 38% ± 22% | |
type I pneumocyte | 7 studies | 31% ± 11% | |
endothelial cell | 6 studies | 31% ± 24% | |
cardiac muscle cell | 5 studies | 30% ± 6% | |
mesothelial cell | 5 studies | 30% ± 10% | |
fibroblast | 4 studies | 28% ± 9% | |
type II pneumocyte | 4 studies | 22% ± 6% | |
Mueller cell | 4 studies | 29% ± 9% | |
endothelial cell of lymphatic vessel | 4 studies | 24% ± 4% | |
epithelial cell | 4 studies | 35% ± 17% | |
ciliated cell | 4 studies | 23% ± 7% | |
myofibroblast cell | 3 studies | 38% ± 3% | |
ependymal cell | 3 studies | 53% ± 15% | |
connective tissue cell | 3 studies | 28% ± 17% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 34% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 9231.59 | 245 / 245 | 100% | 16.01 | 500 / 502 |
uterus | 100% | 14335.26 | 170 / 170 | 82% | 19.33 | 377 / 459 |
thymus | 99% | 2820.92 | 647 / 653 | 82% | 9.03 | 499 / 605 |
ovary | 100% | 5223.33 | 180 / 180 | 78% | 8.25 | 336 / 430 |
esophagus | 93% | 18143.18 | 1351 / 1445 | 79% | 22.37 | 144 / 183 |
bladder | 100% | 12193.00 | 21 / 21 | 66% | 14.27 | 331 / 504 |
breast | 76% | 1989.47 | 351 / 459 | 85% | 17.44 | 955 / 1118 |
brain | 68% | 2203.82 | 1808 / 2642 | 90% | 12.47 | 631 / 705 |
lung | 91% | 1956.37 | 525 / 578 | 66% | 15.32 | 763 / 1155 |
kidney | 97% | 2184.76 | 86 / 89 | 42% | 3.47 | 380 / 901 |
stomach | 99% | 7540.43 | 354 / 359 | 26% | 2.40 | 75 / 286 |
adrenal gland | 72% | 1038.70 | 187 / 258 | 51% | 3.85 | 118 / 230 |
skin | 94% | 3614.07 | 1693 / 1809 | 30% | 3.15 | 141 / 472 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.62 | 1 / 1 |
blood vessel | 99% | 6044.74 | 1327 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 16.39 | 39 / 45 |
intestine | 56% | 1138.00 | 539 / 966 | 21% | 1.50 | 109 / 527 |
adipose | 72% | 1538.59 | 864 / 1204 | 0% | 0 | 0 / 0 |
spleen | 66% | 1053.41 | 158 / 241 | 0% | 0 | 0 / 0 |
pancreas | 1% | 9.75 | 3 / 328 | 63% | 4.97 | 112 / 178 |
muscle | 59% | 870.21 | 473 / 803 | 0% | 0 | 0 / 0 |
heart | 54% | 1029.48 | 467 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 43% | 2.51 | 34 / 80 |
liver | 4% | 45.34 | 8 / 226 | 27% | 2.29 | 110 / 406 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.11 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0038063 | Biological process | collagen-activated tyrosine kinase receptor signaling pathway |
GO_0007528 | Biological process | neuromuscular junction development |
GO_0005604 | Cellular component | basement membrane |
GO_0005615 | Cellular component | extracellular space |
GO_0005587 | Cellular component | collagen type IV trimer |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0031594 | Cellular component | neuromuscular junction |
GO_0030020 | Molecular function | extracellular matrix structural constituent conferring tensile strength |
Gene name | COL4A5 |
Protein name | Collagen, type IV, alpha 5 Collagen type IV alpha 5 chain Collagen type IV alpha 5 transcript variant 2 COL4A5 protein (Collagen type IV alpha 5 chain) Collagen alpha-5(IV) chain COL4A5 protein |
Synonyms | |
Description | FUNCTION: Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen. FUNCTION: Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen. . FUNCTION: Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen. . FUNCTION: Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen. . |
Accessions | ENST00000504541.1 P29400 A0A2R8Y5W0 H0Y9H0 ENST00000328300.11 [P29400-2] A7MBN3 Q49AM6 H0Y998 ENST00000483338.1 ENST00000361603.7 [P29400-1] A0A0A0U994 ENST00000642185.1 ENST00000505728.1 H0Y9R8 V9H0C7 ENST00000515658.1 |